Skip to content
2000
Volume 5, Issue 4
  • ISSN: 2211-7385
  • E-ISSN: 2211-7393

Abstract

Background & Objective: Our research objective was to design, develop, optimize and characterize Granisetron HCl transdermal gel in order to minimize side effects associated with oral delivery. Method: A statistical design was practically applied for further optimization and preparation of transfersomal gel using Box-Behnken methodology at three levels. The selected independent and dependent variables were Lipoid, surfactant and sonication time and encapsulation efficiency, size and flux correspondingly. Result: The optimized formulation (GTV-16) morphology, shape, size, potential, encapsulation capacity and flux (using Franz-diffusion cell assembly via animal skin barricade medium) were determined. Then, GTV-16 incorporated into gel and during evaluation nano-transformal gel has good particle size of 127.7±1.08 nm, better entrapment efficiency of 83.0 ± 3.22 % and flux of 20.0 ± 1.88μgcm-2/h. Conclusion: The results demonstrated that Granisetron Hydrochloride loaded nano-gel was significantly superior with 8.5 fold enhancement in bioavailability as compared with drug solution.

Loading

Article metrics loading...

/content/journals/pnt/10.2174/2211738505666170915151118
2017-12-01
2025-10-28
Loading full text...

Full text loading...

/content/journals/pnt/10.2174/2211738505666170915151118
Loading

  • Article Type:
    Research Article
Keyword(s): Box-Behnken; ex-vivo; gel; granisetron-hydrochloride; transdermal flux; transfersomes
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test